Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

BACKGROUND: The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MU...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chin Med J (Engl)
Asıl Yazarlar: Ge, Jun-Bo, Fan, Wei-Hu, Zhou, Jing-Min, Shi, Hai-Ming, Ji, Fu-Sui, Wu, Yang, Zhao, Yu-Lan, Qian, Jun, Jin, Yuan-Zhe, Liu, Ying-Wu, Wang, Sheng-Huang, He, Sheng-Hu, Yang, Ping, Wu, Jie, Lu, Feng, Hou, Zi-Shan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2021
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817287/
https://ncbi.nlm.nih.gov/pubmed/33273369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001257
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller